Drug Trial Radar · NCT03313596
Multicenter RCT of ADV-TK Gene Therapy Improving the Outcome of Liver Transplantation for Advanced HCC
Last checked: Nov 20, 2026Latest source record: Feb 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
180
Planned (sponsor's estimate)
Start
Mar 2013
Primary completion
Dec 2019
Study completion Dec 2019
Sponsor
- Lead sponsor
- Huazhong University of Science and TechnologyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Beijing YouAn Hospital
- First posted
- Oct 18, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Compare the effect of liver transplantation (LT) plus ADV-TK gene therapy versus LT only in advanced primary hepatocellular carcinoma.
Conditions
- Hepatocellular Carcinoma
Interventions
ADV-TkDrug
The first ADV-TK dose was administered during the operation; 1.0×10(12) viral particles of ADV-TK in 100 mL of 0.9% saline were injected into peritoneum tissues around the liver. The second and third ADV-TK dose was administered 60 days and 90 days after LT; 1.0×10(12) viral particles of ADV-TK in 100 mL of 0.9% saline were injected into the celiac artery (60 mL) and the superior mesenteric artery (40 mL) via femoral-artery puncture.
LTProcedure
Orthotopic LT and subsequent immunosuppression therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survival, PFSTime frame: 2-year
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
301 Military Hospital
Beijing, China · Recruiting
General Hospital of Chinese People's Armed Police
Beijing, China · Recruiting
The Third XiangYa Hospital of Central South University
Changsha, China · Recruiting
West China Hospital of Sichuan University
Chengdu, China · Recruiting
The Third Affiliated Hospital,Sun Yat-sen University
Guangzhou, China · Recruiting
The First Affiliated Hospital, Zhejiang University
Hangzhou, China · Recruiting
Zhongshan Hospital of Fudan University
Shanghai, China · Recruiting
The First Affiliated Hospital of China Medical University
Shenyang, China · Recruiting
The First Center Hospital of Tianjin
Tianjin, China · Recruiting
The First Hospital of Xinjiang Medical University
Ürümqi, China · Recruiting
Beijing Youan Hospital
Beijing, Beijing Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.